← Open Payments lookup

TERRI SCHMIDT: Open Payments

NPI 1992931612 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,839 in 89 payments from 20 companies in 2025. Trend: 2023 $1,630 · 2024 $1,795 · 2025 $1,839

Food & beverage: $1,839
CompanyPaymentsAmount
ABBVIE INC.17$354
AstraZeneca Pharmaceuticals LP14$321
PFIZER INC.12$234
Amgen Inc.9$182
Novo Nordisk Inc8$172
Otsuka America Pharmaceutical, Inc.4$92
GlaxoSmithKline, LLC.4$88
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$65
Boehringer Ingelheim Pharmaceuticals, Inc.3$47
Merck Sharp & Dohme LLC2$45

Products named: VRAYLAR, BREZTRI, NURTEC ODT, OTEZLA, REXULTI, Wegovy, KRYSTEXXA, CAPLYTA.

Industry payments across NV — which companies pay providers there.